Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

The paper presents the results of a standard and complex treatment method using the peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the immunomodulatory effect of thymalin is considered to be the ability of this peptide drug to influence the differentiation of human...

Descripción completa

Detalles Bibliográficos
Autores principales: Khavinson, V. Kh., Kuznik, B. I., Trofimova, S. V., Volchkov, V. A., Rukavishnikova, S. A., Titova, O. N., Akhmedov, T. A., Trofimov, A. V., Potemkin, V. V., Magen, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877506/
https://www.ncbi.nlm.nih.gov/pubmed/33575961
http://dx.doi.org/10.1007/s12015-020-10087-6

Ejemplares similares

Ejemplares similares